ATTN LogoMenu

Canada Goose Extends $300M Term Loan to 2032 as Shares Jump 15%

By ATTN Desk · Editorial oversight: Sean Han

Introduction

Canada Goose Holdings Inc. (NYSE: GOOS), headquartered in Toronto, Ontario, is a Canadian holding company specializing in luxury outerwear and lifestyle apparel. Founded in 1957, the company designs, manufactures, and markets outerwear, accessories, and footwear under the Canada Goose brand (in Korean, 캐나다 구스 홀딩스). Its stated purpose is to "keep the planet cold and the people on it warm," with an emphasis on environmental stewardship and community engagement.

Corporate Structure

Canada Goose employs between 1,001 and 5,000 workers across its global operations. Manufacturing is primarily located in Canada, with facilities in Winnipeg, Scarborough, Boisbriand (Quebec), and Toronto. The company is led by CEO Dani Reiss, with Haider Ackermann appointed as creative director for selected collections in May 2024. Corporate operations are based in Toronto, Stockholm, and New York City, supported by a network of direct‐to‐consumer boutiques and wholesale partners.

Canada Goose

Canada Goose by Gary Bendig

Developments and News

  • August 25, 2025: In a Form 6-K filing, Canada Goose amended its senior secured term loan facility, extending the maturity date to August 23, 2032. The amendment refinanced existing term loans totaling USD 85.96 million and added USD 214.04 million in new borrowings, establishing a total credit capacity of USD 300 million for general corporate purposes.
  • August 14, 2025: Two Schedule 13G/A amendments reported shifts in institutional ownership. Patient Capital Management, LLC and Patient Opportunity Trust reported combined holdings of 1,035,183 shares (approximately 2.25% of outstanding common stock). Separately, Ameriprise Financial, Inc. and Ameriprise Financial Services, LLC disclosed ownership of 2,342,761 shares (5.1%).
  • June 2025: The company published its FY25 Impact Report, outlining progress across its Product, Planet, and People pillars. Events organized by the Inclusion and Belonging Team during Pride Month involved various community engagements, while the Corporate Ambassador Program allowed retail personnel to share insights with global offices. On June 21, Canada Goose acknowledged National Indigenous Peoples Day with storytelling sessions featuring Canada Goose ambassador Sarain Fox.

Financial and Strategic Analysis

As of August 26, 2025, Canada Goose shares closed at USD 14.03, reflecting a 15.28% increase from the previous close, on a trading volume of 306,207 shares. Key financial metrics include:

  • 52-Week Range: USD 6.73 – 15.43
  • Market Capitalization: USD 1.18 billion
  • Trailing P/E Ratio: 34.77; Forward P/E Ratio: 12.18
  • Price/Sales (TTM): 1.21; Price/Book (MRQ): 3.78
  • Profit Margin: 3.44%; Return on Equity (TTM): 12.99%
  • Total Debt/Equity (MRQ): 161.64%; Total Cash (MRQ): USD 180.5 million

The recent amendment to the term loan provides extended maturities and favorable prepayment conditions, assisting in liquidity management and capital allocation. Changes in institutional investor stakes can reflect assessments of growth drivers and financial stability.

Market Position and Industry Context

Canada Goose operates in the global luxury outerwear market, which has experienced increased demand for technical and sustainable apparel. The company distinguishes itself through "Made in Canada" manufacturing, advanced down-filling technology, and initiatives aimed at improving supply chain transparency. Seasonality affects sales, with a higher concentration during colder months, while competition arises from established brands and new market entrants. Canada Goose's strategy focuses on retail expansion, brand experience, and partnerships in Asia and Europe.

TL;DR

On August 26, 2025, Canada Goose shares increased 15.28% to USD 14.03 on high trading volume. On August 25, the company amended its USD 300 million term loan facility to extend maturities to 2032 and improve liquidity. Institutional filings on August 14 indicated combined holdings of approximately 3.38% of common shares by Patient Capital and Ameriprise Financial. The FY25 Impact Report released in June 2025 highlighted corporate social responsibility initiatives, including employee engagement and community celebrations. The adjusted credit facility and investor activities suggest a focus on financial flexibility and ongoing growth.

Latest Stories

Loading articles...